Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction
- PMID: 18272004
- PMCID: PMC2244607
- DOI: 10.1186/1532-429X-10-2
Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction
Abstract
Aims: to investigate the association between admission hyperglycemia and myocardial damage in patients with ST-segment elevation myocardial infarction (STEMI) using Cardiac Magnetic Resonance (CMR).
Methods: We analyzed 113 patients with STEMI treated with successful primary percutaneous coronary intervention. Admission hyperglycemia was defined as a glucose level >/= 7.8 mmol/l. Contrast-enhanced CMR was performed between 3 and 7 days after reperfusion to evaluate left ventricular function and perfusion data after injection of gadolinium-DTPA. First-pass images (FP), providing assessment of microvascular obstruction and Late Gadolinium Enhanced images (DE), reflecting the extent of infarction, were investigated and the extent of transmural tissue damage was determined by visual scores.
Results: Patients with a supramedian FP and DE scores more frequently had left anterior descending culprit artery (p = 0.02 and <0.001), multivessel disease (p = 0.02 for both) and hyperglycemia (p < 0.001). Moreover, they were characterized by higher levels of HbA1c (p = 0.01 and 0.04), peak plasma Creatine Kinase (p < 0.001), left ventricular end-systolic volume (p = 0.005 and <0.001), and lower left ventricular ejection fraction (p = 0.001 and <0.001). In a multivariate model, admission hyperglycemia remains independently associated with increased FP and DE scores.
Conclusion: Our results show the existence of a strong relationship between glucose metabolism impairment and myocardial damage in patients with STEMI. Further studies are needed to show if aggressive glucose control improves myocardial perfusion, which could be assessed using CMR.
Figures


Similar articles
-
Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI.Clin Res Cardiol. 2011 Aug;100(8):649-59. doi: 10.1007/s00392-011-0290-7. Epub 2011 Feb 24. Clin Res Cardiol. 2011. PMID: 21347741
-
Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8. Herz. 2008. PMID: 18344033
-
Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements.Int J Cardiovasc Imaging. 2012 Dec;28(8):1971-81. doi: 10.1007/s10554-012-0021-9. Epub 2012 Feb 5. Int J Cardiovasc Imaging. 2012. PMID: 22310980
-
Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction.Circ Cardiovasc Imaging. 2011 Jul;4(4):354-62. doi: 10.1161/CIRCIMAGING.110.960500. Epub 2011 Apr 25. Circ Cardiovasc Imaging. 2011. PMID: 21518773
-
Acute Hyperglycemia-Induced Injury in Myocardial Infarction.Int J Mol Sci. 2024 Aug 4;25(15):8504. doi: 10.3390/ijms25158504. Int J Mol Sci. 2024. PMID: 39126075 Free PMC article. Review.
Cited by
-
Association of stress hyperglycemia ratio with left ventricular function and microvascular obstruction in patients with ST-segment elevation myocardial infarction: a 3.0 T cardiac magnetic resonance study.Cardiovasc Diabetol. 2024 May 27;23(1):179. doi: 10.1186/s12933-024-02271-6. Cardiovasc Diabetol. 2024. PMID: 38802898 Free PMC article.
-
Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance.J Cardiovasc Magn Reson. 2010 Nov 2;12(1):61. doi: 10.1186/1532-429X-12-61. J Cardiovasc Magn Reson. 2010. PMID: 21044287 Free PMC article.
-
Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction.World J Cardiol. 2017 Feb 26;9(2):109-133. doi: 10.4330/wjc.v9.i2.109. World J Cardiol. 2017. PMID: 28289525 Free PMC article. Review.
-
Novel insights into myocardial fibrosis in patients with new onset ST-elevation myocardial infarction following percutaneous coronary intervention through enhanced cardiac magnetic resonance imaging: a prospective cohort study.BMC Cardiovasc Disord. 2025 Apr 10;25(1):274. doi: 10.1186/s12872-025-04719-3. BMC Cardiovasc Disord. 2025. PMID: 40211110 Free PMC article.
-
Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI.Clin Res Cardiol. 2011 Aug;100(8):649-59. doi: 10.1007/s00392-011-0290-7. Epub 2011 Feb 24. Clin Res Cardiol. 2011. PMID: 21347741
References
-
- Zeller M, Cottin Y, Brindisi MC, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Beer JC, Touzery C, Makki H, Verges B, Wolf JE. The RICO survey working group. Impaired fasting glucose and cardiogenic shock in patient with acute myocardial infarction. Eur Heart J. 2004;25:308–312. doi: 10.1016/j.ehj.2003.12.014. - DOI - PubMed
-
- Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K. Association between hyperglycemia and the no reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1–7. doi: 10.1016/S0735-1097(02)02626-8. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical